Model
Edge
Halozyme Therapeutics, Inc.
0001662521
Filing Type
4
Filing Date
11/30/2025
Updated
12/1/25, 5:50 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership